None listed
Conditions
Brief summary
The objective of the study is to determine the efficacy of a brief mindset intervention in improving participants’ beliefs and perception of low-dose methotrexate used to treat their inflammatory arthritis. The study also aims to investigate whether the brief mindset intervention will result in reduced burden of symptoms associated with methotrexate, and improved adherence in the initial stages of treatment. Specifically, we hypothesise that the intervention group will have more positive beliefs and perceptions towards methotrexate, that they will find associated symptoms less burdensome, and have better initial adherence to the treatment, compared to the active control condition.
Interventions
Viewing methotrexate symptoms as positive signals (SAPS) intervention:
The SAPS intervention will consist of a 5-minute video, delivered on an iPad, by a Health Psychology masters student at Greenlane Clinical Centre in Auckland. The SAPS intervention will be delivered within one-week of the participant starting methotrexate. The SAPS intervention video will provide information about what people can expect when they are using methotrexate to treat their inflammatory arthritis. The video explains
Viewing methotrexate symptoms as positive signals (SAPS) intervention: The SAPS intervention will consist of a 5-minute video, delivered on an iPad, by a Health Psychology masters student at Greenlane Clinical Centre in Auckland. The SAPS intervention will be delivered within one-week of the participant starting methotrexate. The SAPS intervention video will provide information about what people can expect when they are using methotrexate to treat their inflammatory arthritis. The video explains how methotrexate works in the body and the importance of ongoing monitoring of health while taking methotrexate. The video further outlines strategies for how to cope with uncomfortable, but medically safe symptoms that are associated with Methotrexate, particularly through being encouraged to view these uncomfortable but medically safe symptoms as positive signals that the methotrexate is active in the body as intended. Participants will be given a hand out designed specifically for the study that summarises the content of the video before they leave. Two weeks after seeing the SAPS intervention video, participants will receive a booster session via phone call (10-minutes). This booster session will remind participants of the topics covered in the intervention video.
Sponsors
Professor Keith Petrie
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Blinded (masking used) (Subject)
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
New diagnosis of an inflammatory arthritis condition, for which low-dose methotrexate is prescribed. Patients who are attending the rheumatology clinic at Greenlane Clinical Centre in Auckland.
Exclusion criteria
Previous prescription or use of methotrexate. Those who feel unable to complete questionnaires and participate and/or understand English. Lack of access to a phone.
Outcome results
None listed